Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study

2019511 citationsJournal Article

Authors

There was no benefit of adjuvant GEMOX in resected BTC despite adequate tolerance and delivery of the regimen.

Good health and well-being

Published in: Journal of Clinical Oncology

Volume 37, Issue 8, pp. 658-667

Field-Weighted Citation Impact: 61.18